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The epithelial cell-derived cytokine milieu has been discussed as a “master switch” in the devel-
opment of allergic disease.
To understand the role of innate immune response in nasal epithelial cells during allergic
inflammation, we created and established a fast and minimally invasive method to isolate and
culture human nasal epithelial cells from clinically and immunologically well characterized patients.
Human nasal epithelial cells from non-atopic volunteers and from allergic rhinitis patients were
compared in respect to their growth, barrier integrity, pattern recognition, receptor expression,
and immune responses to allergens and an array of pathogen-associated molecular patterns and
inflammasome activators.
Cells from nasal scrapings were clearly identified as nasal epithelial cells by staining of pan-
Cytokeratin, Cytokeratin-14 and Tubulin. Additionally, Mucin 5AC staining revealed the pres-
ence of goblet cells, while staining of tight-junction protein Claudin-1, Occludin and ZO-1
showed the ability of the cells to form a tight barrier. Cells of atopic donors grew slower
than cells of non-atopic donors. All nasal epithelial cells expressed TLR1-6 and 9, yet the
expression of TLR-9 was lower in cells from allergic rhinitis (AR) donors. Additionally, epithelial
cells from AR donors responded with a different TLR expression pattern to stimulation with TLR
ligands. TLR-3 was the most potent modulator of cytokine and chemokine secretion in all
human nasal epithelial cells (HNECs). The secretion of IL-1b, CCL-5, IL-8, IL-18 and IL-33 was
elevated in HNECs of AR donors as compared to cells of non-atopic donors. This was observed
in the steady-state (IL-18, IL-33) as well as under stimulation with TLR ligands (IL-18, IL-33,
CCL-5, IL-8), aqueous pollen extracts (IL-18, IL-33), or the inflammasome activator Nigericin
(IL-1b).
In conclusion, nasal epithelial cells of AR donors show altered physical barrier responses in steady-
state and in response to allergen stimulation. Cells of AR donors show increased expression ofir and Institute of Environmental Medicine, UNIKA-T, Technical
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contribute to a micromilieu which is favorable for Th2.
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of signal exchange between the host and its envi-
ronment. It is becoming increasingly clear, that the
airway mucosa does not only constitute a physical
barrier to irritants and pathogens but also partici-
pates in maintaining the immunological barrier.
For instance, airway epithelial cells express re-
ceptors for pathogen-associated molecular pat-
terns (PAMPs) and respond to microbial antigens
or metabolites by mucus synthesis or production
of chemokines, cytokines, and antimicrobial com-
pounds.1–3
Allergic rhinitis (AR) is caused by hyper-
responsiveness to environmental bioaerosols, such
as house-dust mite feces, fungal spores, or plant
pollen. AR is characterized by acute, recurrent, or
chronic Th2- and IgE-mediated inflammation of
the nasal mucosa, involving the activation of resi-
dent mast cells and dendritic cells as well as tissue
infiltration by immune cells.4 The nasal epithelium
of AR patients is characterized by mucus
hypersecretion, edema, goblet cell hyperplasia,
tissue damage, remodeling,5 and impaired
barrier function.6 As the epithelial cell-derived
cytokine milieu has been found to be a “master
switch” in the development of allergic disease,7
studying the immunobiology of the nasal
epithelium may increase knowledge about the
pathomechanism of AR. Sources for primary cell
cultures are usually explants from surgeries of
normal (turbinectomy) or pathological (polyps,
tumors) tissues. Cultures obtained from these
sources provide decent results, however, it is
difficult to obtain nasal epithelial cells from
individuals with defined sensitization profiles.
Moreover, material obtained from surgical
procedures might not fully mirror physiologic
conditions.
The aim of the present study was to optimize a
minimally invasive method to isolate and culturethese cells with respect to physical and immuno-
logical barrier functions. We therefore compared
HNECs from healthy volunteers and from seasonal
allergic rhinitis (SAR) patients sensitized to pollen
and assessed the growth, pattern recognition re-
ceptor expression, and immune responses to an
array of PAMPs and airborne allergens.METHODS
Cell donors
For nasal curettages, healthy, non-atopic volun-
teers and volunteers with symptomatic seasonal
allergic rhinitis (SAR) and allergic sensitization to
pollen were recruited as cell donors after written
informed consent. Allergic sensitization against a
common aeroallergen panel (tree-, grass- and
weed-pollen, fungal spores, house dust mite, cat
and dog dander, fungal spores) was determined
by serum ImmunoCAP (Thermo Fisher, Massachu-
setts, US). In addition, tissue specimens were ob-
tained during turbinoplastic surgery of otherwise
healthy adult patients with or without SAR. Prior to
surgery, patients gave their written informed con-
sent. Allergic sensitization against common aero-
allergens was determined by serum ImmunoCAP
as described above.
Isolation and expansion of human nasal epithelial
cells from nasal curettages
Human nasal epithelial cells (HNECs) were ob-
tained by scraping the surface of the middle
meatus bilaterally using a rhino-proR curette
(Arlington Scientific, Springville, US). The scraped
cells were sterilized using gentamycin (Invitrogen,
Carlsbad, US) and 100 Antimycotics-Antibiotics
solution (ThermoFisher Scientific, Waltham, MA,
USA) and diluted in Minimal Eagle's Medium
(MEM; ThermoFisher Scientific). Cells were
washed with D-PBS and detached from each other
by resuspending in 0.25% Trypsin-EDTA
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Mitomycin C arrested murine 3T3 fibroblasts as
feeder cells in medium containing a 1:1 mixture of
DMEM (ThermoFisher Scientific) and Ham's F-
12 þ Nutrient Mixture (ThermoFisher Scientific),
10% fetal calve serum (FCS, HyClone, GE Health-
care, South Logan, US), 1% Penicillin/Streptomycin
(ThermoFisher Scientific), and Growth Medium
Supplements of Airway Epithelial Cell Growth
Medium (PromoCell, Heidelberg, Germany).
HNEC-feeder cell co-cultures were incubated at
37 C, 6.5% CO2 for at least 4–5 days before the
first medium change or first passage. For stimula-
tion experiments, second-passage HNECs were
used.Isolation of HNECs from turbinoplastic surgery
specimens
Turbinoplastic surgery specimens were dis-
infected with gentamycin (ThermoFisher Scientific)
and Antimycotics-Antibiotics solution (Thermo-
Fisher Scientific) diluted in MEM, cut into small
pieces, rinsed with D-PBS and the HNECs de-
tached by incubation in 0.25% Trypsin-EDTA and
passing the tissue through a 30 mm cell strainer.
The cells were spun down and half of the cells
were stained immediately for flow cytometry while
the remaining cells were used for culture as
described above.Reagents and allergen extracts
Pollen grains from birch (Betula pendula),
timothy grass (Phleum pratense), and common
ragweed (Ambrosia artemisiifolia) were isolated
from self-collected male inflorescences by sieving,
and aqueous pollen extracts (APEs) were prepared
essentially as described in Gilles S et al.8. Total
protein content was determined by Bradford
assay. For stimulation of HNECs, APEs (Bet-APE:
birch; Phl-APE: timothy grass; Amb-APE:
ragweed) were diluted in Airway Epithelial Cell
Growth Medium (Promocell). House dust mite
(HDM) extract was purchased at Citeq Biologics,
Groningen, The Netherlands; TLR ligands (PolyIC,
LPS, CpG-ODN 2006, Pam3Cys, Flagellin) were
purchased at InvivoGen, Toulouse, France. Niger-
icin was from (Sigma Aldrich, St. Louis, Missouri,
US).Stimulation of HNEC monolayer cultures
HNECs were seeded into 24 or 12 well plates, at
densities of 5  104 cells/ml or 1  105 cells/ml,
respectively, in complete Airway Epithelial Cell
Growth Medium (PromoCell) and grown for 5 days
at 37 C, 5% CO2. At 80% confluence, cultures
were changed to Airway Epithelial Cell Growth
Medium without hydrocortisone and treated with
either flagellin (100 ng/ml), lipopolysaccharide
(LPS; 100 ng/ml), Pam3Cys (1 mg/ml), PolyIC
(10 mg/ml), CPG (5 mg/ml), nigericin (10 ng/ml), or
APEs (1.0 mg total protein/ml). Unstimulated
HNECs served as control. After 24 h IL-1b, CCL-20,
CCL-5, CCL-22, IL-33 (R&D Systems, Minneapolis,
US) IL-1a, CCL-2, IP-10, GM-CSF, IL-8 (BD Phar-
mingen, San Jose, US), IL-18 (eBioscience, San
Diego, US) and HBD-2 (Peprotech, Hamburg,
Germany) were measured in cell culture superna-
tants by ELISA.Stimulation of differentiated HNEC cultures
For transepithelial electrical resistance (TER)
experiments, HNECs were grown in air liquid
interface (ALI) cultures. HNECs were seeded in
Transwell permeable supports (diameter
6.5 mm, polyester membrane with 0.4 mm pores,
Corning Life Sciences) at a density of
1.5  105 cells in complete Airway Epithelial Cell
Growth Medium mixed 1:1 with DMEM (Invi-
trogen). The medium was changed every other
day. After day 5, the medium was aspired from the
apical compartment. Medium of the basolateral
compartment was changed every 2 days. TER was
monitored once a week using a Millicell ERS Volt-
Ohm-meter (Merck, Kenilworth, NJ, US). Experi-
ments were carried out 21 days after the air-lift,
when the cultures reached a TER higher than
2000 U. Therefore, cultures were stimulated
apically with Bet-APE (1.0 mg total protein/ml), Phl-
APE (1.5 mg total protein/ml), Amb-APE (0.5 mg
total protein/ml) or HDM extract (100 mg/ml). EDTA
(10 mmol/ml, Invitrogen) was used as positive
control for TER decrease, and medium treated
wells were used as baseline control. TER was
measured prior to stimulation and monitored over
time. Measurements were normalized with refer-
ence to the values before stimulation (t ¼ 0 h) and
to the control values.
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For investigation of TLR mRNA expression in
unstimulated HNECs, passage one cells were har-
vested, and total RNA was isolated, using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) ac-
cording to manufacturer's instructions. To investi-
gate the TLR expression in TLR-ligand-stimulated
HNECs, the cells were stimulated for 6 h, har-
vested, and total RNA was isolated. RNA concen-
tration and quality were estimated using the
BioDrop Touch spectrophotometer (BioDrop,
Cambridge, UK). The mRNA was reverse tran-
scribed to cDNA using the iScript cDNA Syn-
thesis Kit according to manufacturer's protocol
(BioRad, Munich, Germany). The quantitative real-
time PCR (RT-qPCR) was performed using iTaq
Universal SYBR Green kit (BioRad). Primer se-
quences are shown in suppl. table 1. The PCR
conditions were: 95 C for 30s, followed by 40
cycles of a 5s denaturation step at 95 C and a
30s annealing step at 60 C. A melting curve was
performed at the end of each RT-qPCR run by
increasing the temperature in a stepwise manner
by 0.5 C every 5s, from 60 C to 95 C. For each
primer pair, reaction without template cDNA
served as a negative control (NTC). Additionally,
total RNA was run as template control to check for
possible contamination with genomic DNA (data
not shown). All RT-qPCR reactions were performed
in triplicate with RNA from 2 different sets of
samples. Relative transcript levels were calculated
by the comparative C(T) method9 and multiplied
with (1). GAPDH, Tubulin, 18 S, EF1a, SDHA
and Keratin-18 were tested for suitable house-
keeping controls beforehand (suppl. fig. 1). 18 S
showed to be the most suitable, and therefore it
served as housekeeping control for expression of
TLR and inflammasome genes.
Flow cytometric analysis of HNECs
Surface and cytosolic expression of TLRs and
cytosolic expression of TLR adapter proteins in
HNECs were analyzed using multicolor flow
cytometry. HNECs from conchotomic surgery
specimens and from curettages were subjected
to flow cytometry directly after isolation. Addi-
tionally, HNECs from nasal curettages were stim-
ulated with TLR ligands in 12 well culture plates
for 24 h prior to flow cytometry. The cells werepre-incubated with FcR blocking reagent (Milte-
nyi Biotech, Bergisch Gladbach, Germany) and
subsequently stained with saturating concentra-
tions of PE conjugated mouse anti-CD281/TLR1,
BV421 conjugated mouse anti-CD282/TLR2,
AlexaFluor 700 (AF700) conjugated mouse anti-
CD284/TLR4 (eBioscience), AF647 conjugated
mouse anti-CD285/TLR5, and FITC conjugated
mouse anti-CD286/TLR6 (abcam, Cambridge,
UK). For staining of intracellular antigens, cells
were fixed and permeabilized using the PerFix-nc
kit (Beckman Coulter, Krefeld, Germany)
following the manufacturer's instructions, and
stained with PE conjugated mouse anti-CD283/
TLR3, APC conjugated rat anti-CD289/TLR9 (BD
Pharmingen, Heidelberg, Germany), FITC conju-
gated mouse anti-human TRIF (LifeSpan Biosci-
ence, Seattle, US) and AF405 conjugated mouse
anti-human MyD88 (R&D Systems). Non-viable
cells, staining positive for PromoFluor840 (Pro-
moKine, Heidelberg, Germany), were excluded
from the analysis. For HNECs from conchotomic
surgery specimens PerCP conjugated mouse anti-
CD45 (BD Pharmingen) was used to exclude
leucocytes. FMOs and matched isotype control
mouse antibodies were used in control samples.
Cells were acquired using a Beckmann Coulter
CytoFlex LX flow cytometer equipped with
Cytexpert software (Beckman Coulter). Data were
analyzed using Kaluza software (Beckman
Coulter).Scanning electron microscopy
To characterize the differentiated HNEC cul-
tures, scanning electron microscopy (SEM) was
performed. 14–21 days old ALI cultures of HNECs
with a TER of at least 1000U were fixed with 2%
glutaraldehyde in 1 M cacodylate buffer. Subse-
quently, cells were dehydrated in 1% OsO4 in 1 M
cacodylate buffer (pH 7.2) for 1 h at 4 C, and
finally washed twice with cacodylate buffer. Sam-
ples were then sputtered with 3 nm Au-coating in
order to avoid charging effects. Visualization of the
sample surface was realized by SEM using a Zeiss
Merlin SEM with field emission gun. The SEM was
operated with an acceleration voltage of 3 kV and
a current of 100 pA. Imaging of the topography
was done using an in-lens secondary electron
detector.
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HNECs were seeded into removable 8 well sili-
cone cultivation chambers (ibidi, Planegg, Ger-
many) and grown for 5 days in complete Airway
Epithelial Cell Growth Medium (PromoCell) at
37 C, 5%CO2. At 80–100% confluence cells were
fixed with 4% paraformaldehyde, rinsed, and per-
meabilized with PBS plus 0.1% Triton X and 0.02%
SDS. Subsequently, cells were blocked with 10%
goat serum, incubated with either rabbit anti-wide
spectrum Cytokeratin (1:200, abcam), mouse anti-
Mucin 5AC (1:100, abcam), mouse anti-acetylated
alpha Tubulin (1:200, abcam), mouse anti-
Cytokeratin 14 (Sigma Aldrich) or rabbit anti-
Claudin-1 (1:50, Invitrogen), rabbit anti-ZO-1
(1:50, Invitrogen), mouse anti-Occludin (1:50,
Invitrogen) and then incubated with secondary
antibodies: goat anti-mouse AF488 (1:2000, Invi-
trogen), donkey anti-rabbit AF488 (1:2000, Invi-
trogen) or goat anti-rabbit PE (1:100, Santa Cruz,
Dallas, US). Images were recorded on a DMi8 mi-
croscope using LAS X Life Science microscope
software (Leica, Wetzlar, Germany).
Statistical analysis
We used Mann-Whitney test to compare differ-
ences between 2 groups and one-way ANOVA to
test for significant differences between several
groups. Data of TER measurements were normal-
ized to eliminate high inter-donor variability. To
investigate how dependent variables (cytokine
release; gene expression) were modified by
different stimulation conditions and donor atopy
status (categorical predictors) we applied General
Linear Models (GLM) and full-factorial ANOVA. To
check for significant differences among factors, we
applied post-hoc Bonferroni test. Statistical ana-
lyses were made using Prism version 6.0 (Graph
Pad) or SPSS software (IBM). If not indicated
otherwise, data are presented as mean  standard
error of the mean (SEM). Differences between
samples were considered statistically significant if
p < 0.05.
RESULTS
HNECs from non-atopic donors exhibit faster
growth than cells from allergic rhinitis donors
We first compared the growth characteristics of
HNECs isolated from non-atopic and SAR donors.HNECs from SAR donors showed a tendency to-
wards slower growth than cells from non-atopic
donors (Fig. 1A). Moreover, we observed
significantly higher numbers of viable cells, but
no difference in dead cell counts, and
significantly faster cell growth (days to
confluence) in cultures from non-atopic donors as
compared to SAR donors when first-passage
HNECs were stained with Trypan blue (Fig. 1B).
To determine the effect of the layer of feeder
cells co-seeded with the epithelial cells, HNECs
obtained from curettages were distributed in 2
wells of a 6-well plate – 1 well with mitomycin-
arrested murine 3T3 fibroblasts and 1 well
without. Cell growth kinetics of HNECs on fibro-
blast feeder cells were determined microscopically
by assessing the sizes of epithelial cell “nests”
developed on the feeder layer over time. We
observed that cell growth was only constant in co-
cultures with the fibroblasts (suppl. fig. 2).HNECs from curettages express epithelial cell
markers and form goblet cells
We then analyzed the HNEC via different
microscopic techniques. Immunofluorescence mi-
croscopy of monolayer cultures showed the
expression of cytokeratins with a typical pattern for
epithelial-type cells and an extensive network of
keratin filaments distributed throughout the cyto-
plasm (Fig. 2A). Approximately 20% of the HNECs
expressed Mucin 5AC, a marker of goblet cells,
mainly in the cytoplasm but partly also on the
plasma membrane (Fig. 2B). Beta-IV-Tubulin, a
marker for ciliated cells, was expressed in 60–70%
of the cells, with different straining intensity
(Fig. 2C). Cultures also stained positive for
Claudin-1, ZO-1 and Occludin (Fig. 2D–F). This
was most apparent on the sites of cell-cell-
contacts, suggesting the presence of intact
epithelial tight junctions.
The expression of tight junction genes in HNECs
of non-atopic and SAR donors was compared us-
ing mRNA levels (Fig. 2G). The relative expression
of the MUC5AC and the TJP1 (ZO-1) genes was
similar between non-atopic and SAR cells, but
HNECs from SAR patients showed a statistically
significant reduction in the expression of the CDH1
(E-Cadherin) as well as OCLN (Occludin) genes as
compared to HNECs of non-atopic donors.
Fig. 1 HNECs from non-atopic donors grow faster than HNECs from SAR donors but have similar survival rates. (A) HNECs obtained from
the curettages from non-atopic and AR donors were in a 6 well plate. Cell growth was checked on days 4, 5, 6 and 7 of culture. (B) Time for
reaching confluency in cell culture after isolation and cell count at this time point. n ¼ 7 (dead cell count; days to confluence) n ¼ 10 (live
cell count). Data are depicted as mean  min/max. *p < 0.05 (Mann-Whitney test).
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ALI cultures (Fig. 2H) revealed the presence of
large polygonal non-ciliated epithelial-type cells
but also polygonal cells with different sizes of
microvilli. Additionally, goblet cells with droplets
of mucus attached to their surface were observed.The epithelial integrity is compromised in HNECs
from SAR donors
To analyze the physical epithelial barrier, we
measured the transepithelial electrical resistance
(TER) in ALI cultures of HNECs from non-atopic and
SAR patients. HNECs from SAR patients had a
significantly lower TER than HNECs from non-
atopic donors, starting at 7 days of culture
(Fig. 3A). In HNEC cultures from non-atopic do-
nors, TER did not change in response to aero-
allergen stimulation (Fig. 3B). In contrast, TER
increased in ALI cultures of HNECs from SAR
patients after treatment with pollen or HDM
extracts and the effect was statistically significant
for Phl-APE, Amb-APE and HDM (Fig. 3C).Atopy status affects innate immune receptor
repertoire
To compare the immunological barrier of
HNECs derived from non-atopic and SAR donors,
we first assessed expression of different TLRs in
“steady state”, i.e. in unstimulated monolayer cul-
tures. mRNA levels displayed that HNECs
expressed the genes for TLR-1-6 and 9, MYD88
and TRIF (suppl. fig. 3). HNECs from SAR donors
expressed lower transcript levels of TLR-4 and -9
genes than HNECs from non-atopic donors. TLR-5
and TRIF expression also showed a tendency for
lower expression in SAR donors.
Direct ex vivo flow cytometry of HNECs from
non-atopic and SAR donors was used to assess the
protein levels and showed that TLR-1-4, and 9
were expressed (Fig. 4). The expression of
intracellular TLRs (TLR-3 and -9) was highest,
followed by the extracellular TLR-1, -2 and -4.
Only TLR-9 exhibited a significantly decreased
expression in HNECs derived from atopic donors
as compared to SAR donors. The expression of
Fig. 2 Cells from nasal curettages were identified as human nasal epithelial cells, form tight junctions and contain goblet cells. Exemplary
immunofluorescence staining of HNECs for epithelial cell markers pan-Cytokeratin (A), the goblet cell marker Mucin 5AC (B), the marker for
ciliated cells b-IV-Tubulin (C) and tight-junction proteins Claudin-1 (D), ZO-1 (E) and Occludin (F). Nuclei were visualized by staining with
DAPI. (G) Relative mRNA expression of Mucin 5AC, E-Cadherin, Occludin and ZO-1 as determined by qPCR in HNECs from non-atopic and
AR donors (n ¼ 6 each). *p < 0.05 (Mann-Whitney test). (H) Representative scanning electron micrograph of HNEC air-liquid interphase
cultures. The cultures consisted mainly of large polygonal non-ciliated epithelial-type cells but also contained polygonal cells with different
sizes of microvilli and several goblet cells.
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from SAR donors.
HNECs from non-atopic and SAR donors show
differential responses to TLR stimulation
Stimulation of HNECs with PolyIC induced the
secretion of IL-8, CXCL-10, GM-CSF and CCL-20,
whereas CpG induced the secretion of CCL-22.
These effects were observed in HNECs of non-
atopic and SAR donors alike (suppl. fig. 4). CCL-5
secretion was higher under stimulation with
PolyIC, Pam3Cys, Flagellin and CpG stimulation in
HNECs of SAR as compared to HNECs of non-
atopic donors (Fig. 5A). IL-33 secretion was ab-
sent at baseline and after CpG stimulation in
HNECs from 2 out of 6 non-atopic donors, result-
ing in overall significantly higher IL-33 levels in
HNECs from SAR patients (Fig. 5B). Secretion of IL-18 was increased in HNECs of SAR patients, both
at baseline as well as under all stimulation condi-
tions (Fig. 5C).
HNECs from SAR donors show an altered
inflammasome response
The cytokine results prompted us to investigate
inflammasome activation of HNECs more closely.
We first compared inflammasome-related gene
expression on mRNA level, both at baseline and
under stimulation with TLR ligands (suppl. fig. 5).
HNECs from SAR donors showed significantly
lower overall expression of the genes NLRP3,
CASP1 and AIM2 (p < 0.005), whereas NLRP1
expression was similar in cells of non-atopic and
SAR donors. PolyIC stimulation significantly
reduced AIM2 gene expression in HNECs from
both, non-atopic and SAR donors (p < 0.05).
Fig. 3 Transepithelial resistance differs between air-liquid interphase cultures of HNECs derived from non-atopic and SAR donors. (A)
Stability of transepithelial resistance (TER) over time in air-liquid interphase HNEC cultures of non-atopic and AR donors (n ¼ 9, each). Data
are expressed as mean  SEM. **p < 0.01, ***p < 0.001 (B) TER in cultures from non-atopic (n ¼ 11) and (C) AR donors (n ¼ 9) in response
to stimulation with different aeroallergens (HDM: house dust mite; APE: aqueous pollen extracts; Bet-APE: aqueous birch pollen extract;
Phl-APE: aqueous grass pollen extract; Amb-APE: aqueous ragweed pollen extract). EDTA was used as control to disrupt epithelial
integrity. Data are expressed as mean þ SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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response, we primed the HNECs with TLR ligands
(PolyIC, LPS) and subsequently stimulated with the
inflammasome activator nigericin (Fig. 6). The
overall secretion of IL-33 (Fig. 6A; p < 0.05) and
IL-18 (Fig. 6B; p < 0.005) was significantly
elevated in HNECs of SAR donors as compared
to cells of non-atopic donors, but stimulation had
no significant effect. PolyIC and nigericin specif-
ically induced IL-1b release (Fig. 6C; p < 0.05) in
cells of 3 of the 6 SAR donors, but not in cells of
non-atopic donors. IL-8 secretion was determined
as control for TLR ligand stimulation. It was
induced under PolyIC stimulation solely in cells of
SAR donors (Fig. 6D; p < 0.001). Additional
stimulation with the inflammasome trigger
nigericin did not further enhance the PolyIC-
induced secretion of IL-8 (Fig. 6D).
HNECs of SAR donors secrete elevated levels of
inflammasome-related cytokines in response to
pollen stimulation
Finally we tested whether HNECs from non-
atopic and SAR donors show altered
inflammasome-related cytokine responses to pol-
len exposure (Fig. 7). In accordance with the
previous results, HNECs of SAR donors producedoverall elevated levels of IL-33 (Fig. 7A; p < 0.01)
and IL-18 (Fig. 7B; p < 0.05) as compared to
HNECs of non-atopic donors. Overall levels of IL-
1b did not differ (Fig. 7C). Stimulation of HNECs
with Phl-APE, but not with Bet-APE or Amb-APE
significantly induced the release of IL-18 (Fig. 7B;
p < 0.05) in HNECs of both donor types.
Secretion of the inflammasome unrelated
chemokine IL-8 did not differ overall between
donor types, but was significantly induced by Phl-
APE in cells of non-atopic donors (Fig. 7D;
p < 0.05). In cells of SAR donors, Phl-APE also
induced IL-8, however, the induction was not sta-
tistically significant (Fig. 7D).
In addition, we also tested for expression of a
wider array of other cytokines and chemokines, as
well as the antimicrobial peptide HBD2 under
pollen stimulation (suppl. fig. 6). HBD2 was
induced by Amb-APE mainly in HNECs of SAR
patients (suppl. fig. 6A; p < 0.05) whereas overall
expression of CCL20 (suppl. fig. 6B; p < 0.01)
and CCL22 (suppl. fig. 6C; p < 0.05) was
reduced throughout. IL-1a, GM-CSF, CXCL-10
and CCL-2 did not differ between cells of different
atopy status, nor were they changed by pollen
stimulation (suppl. Fig. 6D–G).
Fig. 4 TLR and TLR adaptor molecule expression differs in HNECs of non-atopic and SAR donors. Direct ex vivo TLR and TLR adaptor
molecule expression in HNECs of non-atopic (n ¼ 11) and AR donors (n ¼ 8). Directly after isolation, HNECs from curettages and biopsies
were stained against TLRs and TLR adaptor molecules and subjected to multi-color flow cytometry. For detection of intracellular proteins,
cells were fixed and permeabilized before staining. Expression levels are given as mean fluorescence intensity (MFI). For each marker, the
MFI of the respective FMO control was subtracted. *p < 0.05 (Mann-Whitney test with Bonferroni multiple testing correction).
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The ability to use human primary cell culture
models in allergy research allows us to harness the
potential to compare responses to stimulation be-
tween cells derived from donors of different atopystatus. Initially, we demonstrate that our method
provides sufficient quantities of viable and func-
tional HNECs from non-atopic donors and other-
wise healthy SAR patients to perform experiments.
Therefore, our expansion protocol could be a
valuable tool to improve existing minimal-invasive
Fig. 5 Patterns of TLR-ligand induced CCL-5, IL-33 and IL-18 release differ in HNECs from non-atopic and SAR donors. (A) CCL-5, (B) IL-33
and (C) IL-18 release of HNECs from non-atopic and AR donors stimulated with different TLR ligands (n ¼ 6, each). Data were analyzed by
General Linear Models (GLM) and full-factorial ANOVA with post-hoc Bonferroni test. Cytokine/chemokine levels were the dependent
variables, stimulation conditions and donor atopy status the categorical predictors. *: significant difference between stimulation conditions;
#: significant difference between cells of different atopy status (non-atopic vs. atopic). ***p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.001.
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confirmed that monolayer and ALI cultures display
an epithelial cell phenotype and contain goblet
cells. In a previous study,10 nasal brushes yielded
the highest cell counts and fastest growth rates,
whereas the cell viability was similar across the
different isolation methods tried. In our study, we
obtained comparable cell numbers using the nasal
curettage technique and cell numbers expandedFig. 6 HNECs from non-atopic and SAR donors differ in their responses
8 release of HNECs from non-atopic and AR donors (n ¼ 6, each) stimu
with or without prior stimulation with LPS or PolyIC. Data were analyze
Dependent variable was cytokine/chemokine release; categorical pred
significant difference between stimulation conditions; #: significant dif
***p < 0.001; #p < 0.05, ###p < 0.001.very rapidly on feeder cells. A previous study
reported diminished levels of E-Cadherin and ZO-
1 in nasal epithelium of AR patients.11 Our results
also mirrored these results, and we observed
decreased E-Cadherin and Occludin transcript
levels in HNECs of SAR when compared to non-
atopic donors. Mucin 5AC immunostaining was
restricted to 20% of cells in our monolayer cultures
designating only a fraction of cells as goblet cells.12to inflammasome stimulation. (A) IL-33, (B) IL-18, (C) IL-1b and (D) IL-
lated with LPS, PolyIC or with the inflammasome activator Nigericin,
d by GLM and full-factorial ANOVA with post-hoc Bonferroni test.
ictors were stimulation condition and donor atopy status. *:
ference between cells of different atopy status. *p < 0.05;
Fig. 7 HNECs of non-atopic and SAR donors show different cytokine responses to stimulation with pollen extracts. Release of (A) IL-33, (B)
IL-18, (C) IL-1b and (D) IL-8 in HNECs from non-atopic and AR donors (n ¼ 6–15) stimulated with different aqueous pollen extracts (Bet-APE:
aqueous birch pollen extract; Phl-APE: aqueous grass pollen extract; Amb-APE: aqueous ragweed pollen extract). Data were analyzed by
GLM and full-factorial ANOVA with post-hoc Bonferroni test. Dependent variable was cytokine/chemokine release; categorical predictors
were stimulation condition and donor atopy status. *: significant difference between stimulation conditions; #: significant difference
between cells of different atopy status. *p < 0.05; #p < 0.05, ##p < 0.01 (ANCOVA with post-hoc Bonferroni test).
Volume 13, No. 3, March 2020 11Beta-IV- tubulin in ALI cultures was positive only on
60–70% of the cells, suggesting that at least a frac-
tion of the cells have the potential to become cili-
ated,13 although we did not observe cilia by SEM.
AR patients have been shown to suffer from
increased epithelial barrier permeability.6,14,15 In
line with this, our ALI cultures derived from SAR
donors showed a decreased TER at all
investigated time points. Interestingly, HDM
extract, Phl-APE and Amb-APE were potent in-
ducers of epithelial resistance but only so in ALI
cultures derived from SAR donors. A previous
study reported similar results in differentiated
bronchial epithelial cell cultures exposed to ex-
tracts of various pollen types, i.e. timothy grass,
ragweed, mugwort, birch and pine.16 Accordingly,
all pollen types induced TER, with timothy grass
pollen being the most potent of all pollen types.
Our HNECs expressed TLR-1-4 and TLR-9 on
mRNA and protein level, with TLR-3 and TLR-9most abundant. TLR-4 and -9 mRNA and TLR-9
protein levels were significantly lower in HNECs
from SAR donors as compared to HNECs of non-
atopic donors. This agrees with a previous study
on sinonasal epithelial cells.17 Likewise, levels of
TLR-4 and -9 were shown to be decreased in
nasal mucosal biopsies of AR patients as
compared to healthy volunteers.18 These results
are of particular interest, as activation of TLR-9 is
known to promote Th1-differentiation and antag-
onize Th2 pathways, an effect which is even more
pronounced in non-allergic subjects.19–21 Apart
from reduced expression of TLR-9 we also
observed a tendency for a decreased expression
of the TLR adaptor molecule TRIF in HNECs
derived from SAR donors. TLR-9 ligation by CpG
was previously shown to result in physical associ-
ation of TLR-9, TRIF and TRAF-6 and downstream
activation of NF-kB, which, in turn, induced IRF-3
and TGF-b-dependent immune suppressive tryp-
tophan catabolism, possibly protecting against
12 Bergougnan et al. World Allergy Organization Journal (2020) 13:100109
http://doi.org/10.1016/j.waojou.2020.100109allergic inflammation.22 Our results showed that
both TLR-9 and TRIF were reduced in SAR as
compared to non-atopic HNECs could indicate a
down-regulated immune suppressive pathway in
SAR nasal epithelium. FACS analysis for TLRs and
adaptor proteins was performed immediately after
isolation and without prior culture to rule out
changes in PRR expression upon prolonged cul-
ture (suppl. fig. 7). Several groups investigated TLR
expression patterns in nasal biopsies in situ, with
conflicting results. Past studies found no
differences in TLR expression between nasal
biopsies from non-atopic and SAR subjects
outside the pollen season but increased nasal TLR-
3 expression in SAR subjects within the pollen
season.23,24 Intranasal challenge with birch pollen
was shown to result in a decrease of TLR-1 and -6
protein expression in nasal biopsies of SAR pa-
tients as compared to non-atopic controls.24 Our
study was restricted to HNECs isolated outside
the main pollen season and levels of TLR-1, -3
and -6 did not differ between HNECs of non-atopic
and SAR donors.
IL-8 was strongly induced in response to timothy
grass pollen extract (Phl-APE). In a recent study,
repeated nasal allergen challenges with low mo-
lecular weight compounds of pollen induced nasal
release of IL-8 in SAR patients and even in non-
atopic subjects in vivo.25 In a study investigating
whole genome transcriptomics of grass pollen
treated airway epithelial cells, the most profound
changes were related to the genes IL-8, IL-6, IL1A
and the transcription factor fos.26 Bronchial
epithelial cells were also shown to release IL-8 in
response to timothy grass pollen, particularly in
response to the pollen-derived flavonoid
isorhamnetin16.
HNECs of our SAR donors secreted elevated
levels of the IL-1 family cytokines, IL-18 and IL-33.
In line with our IL-18 results, elevated nasal IL-18
production has been reported in SAR patients
outside the pollen season.27 IL-18 secretion in our
HNECs was significantly induced by grass pollen
stimulation, irrespective of donor atopy status. This
agrees with our own previous data on human pri-
mary keratinocytes, which induced IL-18 specif-
ically in response to timothy grass pollen
stimulation.28 Chronic or long-term microbial
exposure can go along with elevated tissue IL-33
levels29 and, in the absence of a Th1 stimulus,might favour Th2 differentiation.30 For instance,
nasal and serum IL-33 levels were found
increased in AR patients,31 and baseline IL-33
mRNA expression correlated with late-phase
allergic responses to grass pollen challenges.32
Moreover, IL-33 was shown to be crucial for the
induction of both early- and late-phase responses
in HDM- and ragweed-induced murine allergy
models.33,34
IL-1 family cytokines have been associated with
inflammasome activation.30 HDM, ragweed, and
grass pollen extracts were previously reported to
activate the inflammasome in human
keratinocytes.28,35 In AR patients, nasal levels of
IL-1 family cytokines IL-18 and IL-1a increased
parallel to the pollen season and stayed elevated
for up to 4 weeks after the last pollen peak, indi-
cating activation of inflammasome related path-
ways under natural pollen exposure.27
Accordingly, it was recently reported that the late
phase allergic reaction against grass pollen goes
along with induction of not only Th2-related cyto-
kine genes but also complement and
inflammasome-related genes such as IL-1b.32
When co-stimulating HNECs from SAR patients
with PolyI:C and nigericin we observed a particu-
larly pronounced release of IL-1b in 3 of the 6
patients. Unfortunately, we could not find a com-
mon sensitization pattern specifically shared by
these patients, except for rather low total IgE-
levels, which would be in contrast to previously
published data showing elevated IgE and IL-1b
serum levels in allergic patients.36
In conclusion, our data suggest that HNECs
from AR patients may carry a disturbed innate
immunity, possibly skewing their innate immune
responses away from immune suppression
favouring Th2 pathways and finally triggering al-
lergy induction.
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